Sprott’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$76.6K Hold
10,000
– – ﹤0.01% 247
2026
Q2
$62.4K Hold
10,000
– – ﹤0.01% 257
2026
Q1
$28.3K Hold
10,000
– – ﹤0.01% 235
2025
Q4
$32.5K Hold
10,000
– – ﹤0.01% 211
2025
Q3
$28.7K Buy
+10,000
New +$25.5K ﹤0.01% 205

Other funds holding MRVI

Sprott's MRVI Position: Q3 2026 in Review

Sprott held its Maravai LifeSciences (MRVI) position steady in Q3 2026 at 10,000 shares worth $76.6K. The position accounts for ﹤0.01% of the portfolio, ranked #247.

Sprott first reported a position in MRVI in Q3 2025 and has held it in 5 quarters since. 146 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • Sprott held 10,000 shares of Maravai LifeSciences worth $76.6K as of Q3 2026.
  • Sprott left its Maravai LifeSciences share count unchanged in Q3 2026.
  • Maravai LifeSciences made up ﹤0.01% of Sprott's portfolio in Q3 2026, its #247 holding.
  • Sprott first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 5 quarters since.
  • 146 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Sprott's 13F filing for Q3 2026, filed 9 Nov 2026.